Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Male Subjects With Type II Diabetes (T2DM)”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Early research (Phase 1)Study completedNCT02935712
What this trial is testing

Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)

Who this might be right for
Male Subjects With Type II Diabetes (T2DM)
AstraZeneca 44
Early research (Phase 1)Study completedNCT03646721
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
Dong-A ST Co., Ltd. 108
Early research (Phase 1)Study completedNCT00394030
What this trial is testing

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 63
Early research (Phase 1)Study completedNCT04990427
What this trial is testing

CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Chronic Kidney Diseases
Lisata Therapeutics, Inc. 6
Early research (Phase 1)Study completedNCT02411825
What this trial is testing

Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 76
Early research (Phase 1)Study completedNCT04973111
What this trial is testing

Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose

Who this might be right for
Diabetes
Carmot Therapeutics, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Post-approval studies (Phase 4)Study completedNCT01989754
What this trial is testing

The Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Albuminuria
Janssen Research & Development, LLC 5,813
Post-approval studies (Phase 4)Not Yet RecruitingNCT07116928
What this trial is testing

Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 1,244